Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NIKA PHARMACEUTICALS, INC | Secretary, Director, 10%+ Owner | Preferred A Stock | 10M | Apr 13, 2022 | Direct | ||
NIKA PHARMACEUTICALS, INC | Secretary, Director, 10%+ Owner | Common | $322M | Jun 2, 2023 | Direct | ||
NIKA PHARMACEUTICALS, INC | Secretary, Director, 10%+ Owner | Common | $150M | Jul 20, 2022 | LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKPH | NIKA PHARMACEUTICALS, INC | Apr 29, 2022 | 2 | $250B | 4 | Mar 19, 2024 | Secretary, Director, 10%+ Owner |
NKPH | NIKA PHARMACEUTICALS, INC | Apr 13, 2022 | 9 | $30T | 4 | Mar 19, 2024 | President, CEO, CFO, Director, 10%+ Owner |